Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The KDEL receptor (KDELR) is a seven-transmembrane protein that plays a critical role in maintaining endoplasmic reticulum (ER) proteostasis by retrieving escaped ER-resident proteins from the Golgi apparatus (UniProt, P24555). It specifically recognizes the C-terminal Lys-Asp-Glu-Leu (KDEL) motif or related sequences on proteins, facilitating their retrograde transport via COPI-coated vesicles (PubMed, 29432131). Recent research has identified the KDEL receptor as a signaling molecule that activates G-protein-mediated pathways, such as Gs and Gq, to regulate Golgi-to-ER trafficking and the unfolded protein response (PubMed, 20813264). In oncology, KDELR expression is often upregulated and correlates with increased metastatic potential and poor prognosis in various cancers (PubMed, 31515468). Furthermore, the receptor is exploited by certain bacterial and plant toxins, such as Cholera toxin and Ricin, to gain entry into the ER (PubMed, 11060024). While not a traditional target for small molecule drugs, it is being explored as a mechanism for the targeted delivery of therapeutic proteins and as a potential target for modulating secretory flux in disease states (PubMed, 33483478).
Binding of KDEL-motif containing proteins in the Golgi apparatus followed by retrograde transport to the endoplasmic reticulum via COPI-coated vesicles (PubMed, 29432131).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KDEL endoplasmic reticulum lumen protein retaining receptor (KDELR).